EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CRISPR/Cas-Mediated Knockdown of PD-L1 and KRAS in Lung Cancer Cells

Summer A Abounar, Nefertiti A El-Nikhely iD, Kati Turkowski iD, Rajkumar Savai iD, Hesham Saeed iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25169086 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Summer A Abounar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Institute of Graduate Studies and Research, Alexandria University, Alexandria 21526, Egypt. Hauptthemen laut MEDLINE: B7-H1 Antigen, Proto-Oncogene Proteins p21(ras), Lung Neoplasms, CRISPR-Cas Systems. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Development Fund, The Science, Technology & Innovation Funding Authority (STDF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer cells can escape death and surveillance by the host immune system in various ways. Programmed cell death ligand 1 (PD-L1) is a transmembrane protein that is expressed by most cell types, including cancer cells, and can provide an inhibitory signal to its receptor PD-1, which is expressed on the surface of activated T cells, impairing the immune response. PD-L1/PD-1-mediated immune evasion is observed in several KRAS-mutated cancers. In the current study, we used the CRISPR/Cas9 system to knock down PD-L1 and KRAS in adenocarcinoma lung cells (A549 and H1975). Knockdown of PD-L1 was validated by qPCR and coculture with lymphocytes. The cells were functionally analyzed for cell cycle, migration and apoptosis. In addition, the effects of PD-L1 and KRAS downregulation on chemotherapy sensitivity and expression of inflammatory markers were investigated. Suppression of PD-L1 and KRAS led to a slowdown of the cell cycle in the G0/G1 phase and reduced migration, increased sensitivity to chemotherapy and triggered apoptosis of cancer cells. In addition, the conditioned medium of the modulated cells significantly affected the native cancer cells and reduced their viability and drug resistance. Our study suggests that dual silencing of PD-L1 and KRAS by CRISPR/Cas9 may be a promising therapeutic approach for the treatment of lung cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B7-H1 AntigenProto-Oncogene Proteins p21(ras)Lung NeoplasmsCRISPR-Cas SystemsApoptosisGene Knockdown TechniquesHumansCell Line, TumorA549 CellsCell MovementGene Expression Regulation, NeoplasticCell Cycle

Stichwörter der Autor:innen

CRISPRKRASPD-L1cancerlung

Substanzen

B7-H1 AntigenProto-Oncogene Proteins p21(ras)KRAS protein, humanCD274 protein, human

Autor:innen und Institutionen

  • Department of Biotechnology, Institute of Graduate Studies and Research, Alexandria University, Alexandria 21526, Egypt.
  • Program of Molecular Biotechnology, Faculty of Advanced Basic Sciences, Alamein International University, New Alamein City, Marsa Matrouh 5060310, Egypt.
  • Lung Microenvironmental Niche in Cancerogenesis, Institute for Lung Health (ILH), Justus Liebig University, 35390 Giessen, Germany.

ORCID-Profile: Nefertiti A El-Nikhely, Kati Turkowski, Rajkumar Savai, Hesham Saeed

Förderung

  • Science and Technology Development Fund
  • The Science, Technology & Innovation Funding Authority (STDF)

Zitieren

APA

Abounar, S. A., El-Nikhely, N. A., Turkowski, K., Savai, R., & Saeed, H. (2024). CRISPR/Cas-Mediated Knockdown of PD-L1 and KRAS in Lung Cancer Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25169086

Vancouver

Abounar SA, El-Nikhely NA, Turkowski K, Savai R, Saeed H. CRISPR/Cas-Mediated Knockdown of PD-L1 and KRAS in Lung Cancer Cells. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25169086

BibTeX
@article{Abounar2024,
  author = {Abounar, Summer A and El-Nikhely, Nefertiti A and Turkowski, Kati and Savai, Rajkumar and Saeed, Hesham},
  title = {CRISPR/Cas-Mediated Knockdown of PD-L1 and KRAS in Lung Cancer Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25169086}
}
Kostenlos starten →